Pre-Market Earnings Report for February 25, 2013 : LOW,

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz

Pre-Market Earnings Report for February 25, 2013 : LOW, FE, HTZ, DCI, KOS, ARIA, DDD, BGC, CTB, CWH, HL, DNDN

By NASDAQ.com News , February 22, 2013, 04:00:03 PM EDT

The following companies are expected to report earnings prior to market open on 02/25/2013. Visit our Earnings Calendar for a full list of expected earnings releases.

Lowe's Companies, Inc. ( LOW ) is reporting for the quarter ending January 31, 2013. The building company's consensus earnings per share forecast from the 20 analysts that follow the stock is $0.23. This value represents a -20.69% decrease compared to the same quarter last year. LOW missed the consensus earnings per share in the 3rd calendar quarter of 2012 by -7.14%. Zacks Investment Research reports that the 2013 Price to Earnings ratio for LOW is 21.90 vs. an industry ratio of 18.80, implying that they will have a higher earnings growth than their competitors in the same industry.

FirstEnergy Corporation ( FE ) is reporting for the quarter ending December 31, 2012. The electric power utilities company's consensus earnings per share forecast from the 7 analysts that follow the stock is $0.79. This value represents a 2.60% increase compared to the same quarter last year. Zacks Investment Research reports that the 2012 Price to Earnings ratio for FE is 11.98 vs. an industry ratio of 8.60, implying that they will have a higher earnings growth than their competitors in the same industry.

Hertz Global Holdings, Inc ( HTZ ) is reporting for the quarter ending December 31, 2012. The business services company's consensus earnings per share forecast from the 6 analysts that follow the stock is $0.32. This value represents a 33.33% increase compared to the same quarter last year. In the past year HTZ has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 5%. Zacks Investment Research reports that the 2012 Price to Earnings ratio for HTZ is 13.78 vs. an industry ratio of 37.50.

Donaldson Company, Inc. ( DCI ) is reporting for the quarter ending January 31, 2013. The pollution control company's consensus earnings per share forecast from the 10 analysts that follow the stock is $0.38. This value represents a 8.57% increase compared to the same quarter last year. In the past year DCI has met analyst expectations twice and beat the expectations the other two quarters. Zacks Investment Research reports that the 2013 Price to Earnings ratio for DCI is 20.84 vs. an industry ratio of 9.20, implying that they will have a higher earnings growth than their competitors in the same industry.

Kosmos Energy Ltd. ( KOS ) is reporting for the quarter ending December 31, 2012. The international company's consensus earnings per share forecast from the 6 analysts that follow the stock is $0.05. This value represents a -44.44% decrease compared to the same quarter last year. Zacks Investment Research reports that the 2012 Price to Earnings ratio for KOS is -49.05 vs. an industry ratio of 19.90.

ARIAD Pharmaceuticals, Inc. ( ARIA ) is reporting for the quarter ending December 31, 2012. The drug company's consensus earnings per share forecast from the 14 analysts that follow the stock is $-0.36. This value represents a -5.26% decrease compared to the same quarter last year. Zacks Investment Research reports that the 2012 Price to Earnings ratio for ARIA is -15.77 vs. an industry ratio of 5.20.

3D Systems Corporation ( DDD ) is reporting for the quarter ending December 31, 2012. The computer company's consensus earnings per share forecast from the 3 analysts that follow the stock is $0.37. This value represents a 48.00% increase compared to the same quarter last year. DDD missed the consensus earnings per share in the 2nd calendar quarter of 2012 by -11.11%. Zacks Investment Research reports that the 2012 Price to Earnings ratio for DDD is 47.32 vs. an industry ratio of 21.30, implying that they will have a higher earnings growth than their competitors in the same industry.

General Cable Corporation ( BGC ) is reporting for the quarter ending December 31, 2012. The wire and cable company's consensus earnings per share forecast from the 4 analysts that follow the stock is $0.29. This value represents a -3.33% decrease compared to the same quarter last year. The "days to cover" for this stock exceeds 14 days. Zacks Investment Research reports that the 2012 Price to Earnings ratio for BGC is 16.00 vs. an industry ratio of 16.50.

Cooper Tire & Rubber Company ( CTB ) is reporting for the quarter ending December 31, 2012. The rubber tire company's consensus earnings per share forecast from the 7 analysts that follow the stock is $0.85. This value represents a 66.67% increase compared to the same quarter last year. In the past year CTB has beat the expectations every quarter. The highest one was in the 3rd calendar quarter where they beat the consensus by 34.48%. Zacks Investment Research reports that the 2012 Price to Earnings ratio for CTB is 8.12 vs. an industry ratio of 8.00, implying that they will have a higher earnings growth than their competitors in the same industry.

CommonWealth REIT ( CWH ) is reporting for the quarter ending December 31, 2012. The reit company's consensus earnings per share forecast from the 4 analysts that follow the stock is $0.85. This value represents a 11.84% increase compared to the same quarter last year. CWH missed the consensus earnings per share in the 4th calendar quarter of 2011 by -10.59%. Zacks Investment Research reports that the 2012 Price to Earnings ratio for CWH is 5.20 vs. an industry ratio of 15.60.

Hecla Mining Company ( HL ) is reporting for the quarter ending December 31, 2012. The mining company's consensus earnings per share forecast from the 8 analysts that follow the stock is $0.04. This value represents a -33.33% decrease compared to the same quarter last year. Zacks Investment Research reports that the 2012 Price to Earnings ratio for HL is 49.00 vs. an industry ratio of 9.60, implying that they will have a higher earnings growth than their competitors in the same industry.

Dendreon Corporation ( DNDN ) is reporting for the quarter ending December 31, 2012. The biomedical (gene) company's consensus earnings per share forecast from the 18 analysts that follow the stock is $-0.55. This value represents a -311.54% decrease compared to the same quarter last year. Zacks Investment Research reports that the 2012 Price to Earnings ratio for DNDN is -1.99 vs. an industry ratio of -19.10, implying that they will have a higher earnings growth than their competitors in the same industry.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Firmable's Tech Intelligence: New Edge in B2B Sales

Updated Category News Views 18

New Era for B2B Sales Teams Once again, the B2B sales landscape is getting a jolt—especially for those who’ve been fumbling in the dark pitching to prospects without any real idea of their tech environment. With the introduction of Firmable's Tech Intelligence, those blind days just got a lot brighter. By offering detailed insights into what technologies a company is...

Continue Reading
New Jersey Homeowners Face Mold Risks in Crawl Spaces

Updated Category News Views 14

Understanding the Invisible Threat of Crawl Space Mold Crawl space mold—it hides in the shadows beneath your home, biding its time until it wreaks havoc on indoor air quality. In the context of New Jersey's environmental quirks, this isn't a trivial concern. With humidity hanging around like an unwanted guest and sneaky water intrusions, those dark nooks under houses...

Continue Reading
DOCS Faces Investor Legal Battle for Alleged Misconduct

Updated Category News Views 11

The DOCS Predicament: Investors Facing Class Action Doximity, Inc., trading as NYSE:DOCS, finds itself in hot water again as shareholders gear up for a legal skirmish over alleged securities fraud. Schall, Brown & Schwartz LLP, the firm rallying the shareholders, has fired the opening salvo, pointing fingers at Doximity for cooking the books about their Newsfeed’s...

Continue Reading
National Showrooms Expands into Virginia with Key Buy

Updated Category News Views 11

A New Chapter for Greenwich Kitchens I'll tell you what's catching my eye this time—National Kitchen & Bath Showrooms are making their move into Virginia by snapping up Greenwich Kitchens, a well-regarded name in the local kitchen and bath scene. Founded back in '78, Greenwich Kitchens has been a staple in the Virginia Beach and Hampton Roads areas for nearly half a...

Continue Reading
Coastal Financial Faces Lawsuit Over Fraud Allegations

Updated Category News Views 8

Coastal Financial Corporation, riding high on NASDAQ as CCB, now finds itself in the middle of a storm. Schall, Brown & Schwartz LLP, a firm known for its shareholder rights litigation, has thrown the gauntlet with a class action lawsuit against Coastal for suspected securities violations. We're talking about potential fibs under Section 10(b) and 20(a) of the Securities...

Continue Reading
De¹ Unveils Tokenization Model on BNB Chain

Updated Category News Views 15

De¹'s Bold Move into Enhanced Digital Finance Just when you thought the financial landscape couldn’t get any more complex, De¹ steps into the ring with its Tokenized Asset World on the BNB Chain—a move that's stirring the pot of tokenized finance in more ways than one. For old-school investors who thrive on waving outlandish stock bets, this crypto narrative is a...

Continue Reading
JELD-WEN CFO Transition: Navigating Finances Amid Changes

Updated Category News Views 5

Leadership Shake-up at JELD-WEN Alright, folks, the boardroom saga over at JELD-WEN just took another spin. Samantha Stoddard, the brain behind the numbers as Chief Financial Officer, is packing her bags come mid-November. Yeah, she's off to chase new horizons outside the realm of building products, leaving a spot hotter than a New York Stock Exchange ring bell up for...

Continue Reading
Workday Hits High Note in 2026 Gartner Magic Quadrant

Updated Category News Views 14

Workday Secures Leadership Position In a wild ride that's left investors with whiplash in recent years, Workday (NASDAQ: WDAY) has firmly planted its flag at the top tier of the 2026 Gartner® Magic Quadrant™ for Cloud ERP Finance. This announcement out of Pleasanton, California, resonates like a victory bell for the company's finance management solutions—a mix of AI,...

Continue Reading
Brown Plus Ranks #8 Best Workplace for Women 2026

Updated Category News Views 4

Cracking the Top Ten: A Noteworthy Feat When it comes to hustling and bustling in the corporate world, Brown Plus managed to snag the spotlight by landing the #8 spot in the 'Best Place to Work for Women 2026.' It's a title they didn't just stumble upon. This recognition in the medium category by the Best Companies Group underscores the fact that Brown Plus is running its...

Continue Reading
OppFi Readies Q3 Earnings; Investors Eye Financials

Updated Category News Views 10

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

Continue Reading

Top 5 Most Recently Viewed Articles

Grindr Inc. Board Under Investigation: Shareholder Rights at Stake

Updated Category News Views 164

Grindr Inc. Investigation Overview Grindr Inc. is currently facing a significant investigation concerning its board of directors, primarily focused on potential breaches of fiduciary duties. The investigation is centered around a proposed deal that could notably affect the interests of minority shareholders. This situation raises essential questions about the obligations...

Continue Reading
Abridge's New Research Initiative: Transforming Healthcare with AI

Updated Category News Views 226

Back in 2024, Abridge launched its Research Collaborative to dive into how ambient AI could shake up the healthcare game. They weren’t just throwing darts blindfolded; they aimed at some key issues: improving clinician and patient experiences, cutting down on costs, boosting outcomes, and promoting health equity. You know how it is—everyone’s talking about...

Continue Reading
Empowering Girls: Addressing Gender Equality in Education

Updated Category News Views 303

Education Cannot Wait's Commitment to Gender Equality In a powerful move to bolster gender equality in education, Education Cannot Wait (ECW) has launched groundbreaking grants totaling $1.9 million. This funding aims to support girls who often encounter substantial barriers in accessing quality education during emergencies and prolonged crises. Partnerships for Change...

Continue Reading
Vaccinex Shares Slide to Record Low Despite Clinical Promises

Updated Category News Views 96

Vaccinex’s Stock Drop and Ongoing Developments This past year has been quite tough for Vaccinex, Inc. (NASDAQ: VCNX), a biotech company focused on improving patient care with innovative therapies. Recently, its stock has fallen to a notable 52-week low of $4.17, marking a dramatic 75.4% drop over the year. This decline reflects not just numbers but also growing concerns...

Continue Reading
RenovoRx Welcomes Acclaimed Oncologist to Scientific Board

Updated Category News Views 119

RenovoRx Boosts Scientific Expertise with New Board Member RenovoRx, Inc. (NASDAQ: RNXT), a pioneering life sciences company focused on advancing targeted oncology therapies, is excited to announce the addition of Dr. Thierry de Baère, an acclaimed interventional oncologist, to its Scientific Advisory Board (SAB). This strategic move underscores the company’s...

Continue Reading